<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01814007</url>
  </required_header>
  <id_info>
    <org_study_id>ZA13-001</org_study_id>
    <nct_id>NCT01814007</nct_id>
  </id_info>
  <brief_title>Multiple Treatment Study</brief_title>
  <official_title>SAFETY EVALUATION OF MULTIPLE COOLSCULPTING TREATMENTS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zeltiq Aesthetics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zeltiq Aesthetics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate if multiple same-day CoolSculpting treatments increase the risk of abnormal
      lipids and liver-related tests.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of lipid levels</measure>
    <time_frame>12-weeks post treatment</time_frame>
    <description>Blood draws will be collected at various intervals, after the multiple treatments have been performed, and analyzed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>12 weeks post treatment</time_frame>
    <description>Incidence and severity of all reported adverse events and clinical assessment of any side effects/pain in the treatment area.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Body Fat Disorder</condition>
  <arm_group>
    <arm_group_label>Fat Reduction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The Zeltiq System</intervention_name>
    <description>Non-invasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
    <arm_group_label>Fat Reduction</arm_group_label>
    <other_name>Cryolipolysis</other_name>
    <other_name>Lipolysis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Male or female subjects &gt; 18 years of age.

          -  Subject who has been assessed to receive multiple CoolSculpting treatments on the
             abdomen and flanks, defined as follows:

               1. Lower Abdomen - One 60 minute cycle with CoolMax,

               2. Right and Left Flank - One 60 minute cycle per flank, with CoolCurve+ or
                  CoolCore, simultaneously.

          -  Subject has not had weight change exceeding 10 pounds in the preceding month.

          -  Subject with body mass index (BMI) up to 30. BMI is defined as weight in pounds
             multiplied by 703 divided by the square of the height in inches.

          -  Subject agrees to not making any major changes in their diet or lifestyle during the
             course of the study.

          -  Subject has read and signed a written informed consent form.

        Exclusion Criteria

          -  Subject has had an invasive (e.g., liposuction, mesotherapy, abdominoplasty) or
             non-invasive fat reduction and/or body contouring procedure in the area of intended
             treatment within the past 6 months.

          -  Subject needs to administer, or has a known history of subcutaneous injections into
             the area of intended treatment (e.g., heparin, insulin) within the past month.

          -  Subject has a known history of cryoglobulinemia, cold urticaria, or paroxysmal cold
             hemoglobinuria.

          -  Subject has a history of hernia in the area(s) to be treated.

          -  Subject is pregnant or intending to become pregnant during the study period (in the
             next 4 months).

          -  Subject is lactating or has been lactating during the past 3 months.

          -  Subject is unable or unwilling to comply with the study requirements, such as blood
             draw.

          -  Subject is currently enrolled in a clinical study of any other unapproved
             investigational drug or device.

          -  Subject has a history of lipodosis or other confounding metabolic diseases.

          -  Subject is taking or has taken medication within the past 3 months which may affect
             the metabolic function.

          -  Patient has a history of diabetes.

          -  Any other condition or laboratory value that would, in the professional opinion of the
             investigator, potentially affect the subject's response or the integrity of the data
             or would pose an unacceptable risk to the subject.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Bachelor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Innovation Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Innovation Research Center</name>
      <address>
        <city>Pleasanton</city>
        <state>California</state>
        <zip>94588</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ed Becker, MD</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bowes Dermatology Group</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2013</study_first_submitted>
  <study_first_submitted_qc>March 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2013</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lipolysis</keyword>
  <keyword>Cryolipolysis</keyword>
  <keyword>Fat Reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

